The Role of Patient Involvement When Developing Therapies

5Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The drug development process is a long and arduous one, especially for rare diseases. Patient and patient representatives can and should be involved in this process from an early stage, since they have the perspective of living with a disease on a daily basis and can best identify which symptoms are the largest burden and which benefits would be more important to them. In this perspective, we outline how patients can be involved optimally in drug development. We outline success factors such as finding the right partners, bilateral education, having realistic expectations, and an open and honest dialog with all stakeholders.

Cite

CITATION STYLE

APA

Aartsma-Rus, A., Vroom, E., & O’Reilly, D. (2022). The Role of Patient Involvement When Developing Therapies. Nucleic Acid Therapeutics, 32(2), 118–122. https://doi.org/10.1089/nat.2021.0048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free